Sugar-sweetened beverages and cardiovascular disease risk: an RCT

含糖饮料和心血管疾病风险：随机对照试验

• 批准号: 8508292
• 负责人: DAVID S LUDWIG
• 金额: $ 71.5万
• 依托单位: BOSTON CHILDREN'S HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-08-14 至 2016-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8508292
• 关键词: Adverse effects; Alanine Transaminase; Animals; Artificial Sweeteners; Attention; Awareness; Behavioral; Beverages; Biological; Blood Pressure; Body Weight; Body Weight decreased; Body fat; C-reactive protein; Cardiovascular Diseases; Cell physiology; Clinical Trials; Consumption; Descriptor; Development; Diet; Dietary Fiber; Dual-Energy X-Ray Absorptiometry; Effectiveness; Fabaceae; Fibrinogen; Food; Health; Health Benefit; High Density Lipoprotein Cholesterol; Home environment; Hour; Individual; Intake; Interview; Knowledge; LDL Cholesterol Lipoproteins; Left; Link; Liquid substance; Marketing; Measures; Metabolic syndrome; Methods; Micronutrients; Mineral Waters; Non-Insulin-Dependent Diabetes Mellitus; OGTT; Obesity; Observational Study; Outcome; Plasminogen Activator Inhibitor 1; Public Health; Randomized; Randomized Controlled Trials; Risk; Risk Factors; Sampling; Sensory; Serum; Solid; Solutions; Staging; Taste Perception; Tea; Testing; Triglycerides; Uric Acid; Urine; Water; Weight Gain; Work; base; cardiovascular disorder risk; control trial; diabetes risk; fruits and vegetables; hedonic; improved; insulin sensitivity; preference; prospective; public health relevance; research study; response; sugar; sweet taste perception; sweetened beverage; targeted delivery; waist circumference; young adult

DESCRIPTION (provided by applicant): Consumption of sugar sweetened beverages (SSB) has been linked to obesity and, independent of body weight, risk for diabetes and cardiovascular disease. With rising public health awareness of these potential adverse effects, consumption of artificially sweetened beverages (ASB) has increased dramatically. These low-calorie products are marketed as "diet," with the implication that they promote weight loss and improved health. However, there are no long term experimental studies of ASB and body weight or any other health outcome. Several recent prospective observational studies have linked intake of ASB to increased risk of the metabolic syndrome, type 2 diabetes, and obesity. In the proposed clinical trial, 270 young adults who habitually consume SSB will be randomly assigned to one of three groups: 1) to continue consuming habitual levels of SSB; 2) to substitute ASB for SSB; or 3) to substitute unsweetened beverages for SSB. Each group will receive home delivery of the targeted beverage for 1 year, using methods that build upon previous successful work. Careful attention will be given to assuring treatment fidelity, equivalence of treatment intensity, and avoidance of experimental confounders. The primary study endpoint will be the ratio of serum triglyceride to HDL-cholesterol concentrations. Secondary endpoints will include changes in other cardiovascular disease risk factors, body weight, dietary quality, and taste preferences.

描述（由申请人提供）：含糖饮料（SSB）的消费与肥胖有关，并且与体重无关，糖尿病和心血管疾病的风险有关。随着公众对这些潜在不良影响的认识不断提高，人工增甜饮料（ASB）的消费量急剧增加。这些低热量的产品被称为“减肥”，暗示它们可以促进减肥和改善健康。然而，没有ASB和体重或任何其他健康结果的长期实验研究。最近的几项前瞻性观察性研究将ASB的摄入与代谢综合征，2型糖尿病和肥胖的风险增加联系起来。在拟议的临床试验中，270名习惯食用SSB的年轻人将被随机分配到三组之一：1）继续食用习惯水平的SSB; 2）用ASB代替SSB;或3）用不加糖的饮料代替SSB。每个小组将收到一年的目标饮料送货上门，使用的方法，建立在以前的成功工作。将仔细注意确保治疗保真度、治疗强度的等效性和避免实验混杂因素。主要研究终点为血清甘油三酯与HDL-胆固醇浓度的比值。次要终点将包括其他心血管疾病风险因素、体重、饮食质量和口味偏好的变化。